Re:Treat Medicines Like Netflix Treats Shows
by ummonk on Thursday March 07, 2019 @11:39AM
(#19329479)
I imagine the Hep C drugs are some of the more monetizable drugs though and will need to rake in more money to subsidize the development of niche drugs.
From the link, it looks like it costs ~$10bn per successful drug, at the top end of that list.
Australia paid $750m for 5 years access.
Australia has ~1/10th the population of the United States. and ~1/3rd the population of the UK.
If just the UK, USA and Australia paid at that same rate (per capita) then they would cover that 10bn average development cost in 5 years.
Seems like it's a good suggestion